What we're reading on October 12, 2015: health insurance marketplaces may have challenges keeping customers they already have, but in California, consumers leaving the state insurance exchange are gaining coverage elsewhere, and the government is increasingly pursuing cases of potentially unnecessary procedures.
A close study of one patient-reported outcome has deemed it a clinically valuable measure, according to a study published in the Journal of the American College of Surgeons.
The PD-1 inhibitor antibody was approved by the FDA for use in patients who have progressed on platinum-based treatment.
Steven Rosenberg, MD, chief of surgery at NCI's Center for Cancer Research, has been awarded the 2015 Samuel J. Heyman Service to America Medal, or Sammie for his contributions to the field of immune-based cancer treatments.
The PD-L1 inhibitor was granted orphan drug status just last month.
Coverage expansions resulting from the Affordable Care Act have not had a negative financial effect on medical practices. Instead, primary care physicians reported increased collections and decreased visit volume, according to athenahealth
The recent overview of obesity from the Trust for America's Health revealed extremely high percentages of Native Americans are overweight and obese, especially in states where they live in remote locations.
The study plans to evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
Researchers say the results may help physicians better target screening for obese youth.
The CHHiP trial found fewer high-dose radiotherapy was as effective as more number of low-dose radiotherapy in men with prostate cancer.
Posters focus on next-generation sequencing ovarian cancer and identify candidates for treatment with PARP inhibitors.
The research could hold the key to a novel treatment for type 2 diabetes, although it will take years to adapt the idea to clinical practice.
The collaboration will make available 3 fully-humanized monoclonal antibodies to fight the devastating virus.
As enrollment in Medicare Advantage is expected to increase to a new all-time high for the sixth year in a row, CMS announced that Medicare Advantage premiums will remain stable in 2016.
An analysis of the competitive landscape of the public health insurance exchanges as it has so far unfolded has revealed that despite challenges to date, the exchanges have been attracting new entrants.
Work at the Karolinska Institutet has revealed a potential new therapeutic target in type 2 diabetes.
Nearly half a billion dollars in Affordable Care Act funding will be awarded to health centers around the country to help them provide primary care services to those who need them most.
The American Society of Clinical Oncology has urged Congress to recognize the impact of barriers to interoperability of electronic health records on patient outcomes.
Researchers analyzed patient records from a 25-year period and found risks increased with higher doses and longer periods of treatment.
Unaccounted for social and clinical characteristics of a hospital's patient population explain nearly half of the difference in readmission rates between the best and the worst performing hospitals when it comes to Medicare penalties for hospital readmission rates.
Although a new report from The Commonwealth Fund raised concerns about the competition of Medicare Advantage (MA) programs available across the country, a new analysis from Avalere Health found that there has been a growing number of MA plan options for consumers.
Over 10 million personal records of Excellus BlueCross BlueShield customers were jeopardized when hackers gained access to the health plan's database.
FDA has warned that the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling. In a statement, the FDA said said it had issued a "warning and precaution" to all labels in this drug class.
Research has shown that telehealth has the potential for better care at lower costs and with increased convenience, but the issue of paying for this service has yet to be addressed.
Predictive modeling determined that the needle exchange in Washington, DC, prevented 120 new cases of HIV in 2 years, according to researchers.
Rolapitant was approved to prevent delayed phase chemotherapy-induced nausea and vomiting in adult patients.
Approval for the technology, which integrates with a smartphone, came sooner than company officials expected.
Pharmacy cost trends are expected to increase 10% up from 6.3% the year before, with specialty pharmacy trends experiencing the largest increases, according to a survey from Aon Health.
Although the fee-for-service model of reimbursement has been blamed as an reason for high healthcare costs in America, a report from HealthPocket found that eliminating this payment model in provider-owned health plans did not produce the cheapest health plans.
A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.